Cornerstone Advisors (Washington)’s Globus Medical GMED Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$8K	Buy	167 +63	+61%	+$3.25K	﹤0.01%	454
2020 Q2	$5K	Sell	104 -52	-33%	-$2.51K	﹤0.01%	499
2020 Q1	$7K	Sell	156 -335	-68%	-$16.6K	﹤0.01%	452
2019 Q4	$29K	Sell	491 -51	-9%	-$2.77K	﹤0.01%	310
2019 Q3	$28K	Sell	542 -302	-36%	-$14.4K	﹤0.01%	295
2019 Q2	$36K	Hold	844	–	–	﹤0.01%	486
2019 Q1	$42K	Sell	844 -13	-2%	-$588	﹤0.01%	417
2018 Q4	$37K	Sell	857 -622	-42%	-$31K	0.01%	363
2018 Q3	$84K	Hold	1,479	–	–	0.05%	238
2018 Q2	$75K	Buy	1,479 +1,466	+11,277%	+$76.4K	0.05%	241
2018 Q1	$1K	Buy	+13	New	+$611	﹤0.01%	969

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Cornerstone Advisors (Washington)'s GMED Position: Q3 2020 in Review

Cornerstone Advisors (Washington) increased its Globus Medical (GMED) stake by 61% in Q3 2020, buying an estimated $3.25K and bringing the position to 167 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

Cornerstone Advisors (Washington) first reported a position in GMED in Q1 2018 and has held it in 11 quarters since. The position peaked at $84K in Q3 2018. 344 funds tracked by Wall St. Rank hold GMED as of Q3 2020.

Cornerstone Advisors (Washington) held 167 shares of Globus Medical worth $8K as of Q3 2020.
Cornerstone Advisors (Washington) bought 63 Globus Medical shares in Q3 2020, an estimated $3.25K.
Globus Medical made up ﹤0.01% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #454 holding.
Cornerstone Advisors (Washington) first reported a position in Globus Medical in Q1 2018 and has held it in 11 quarters since.
Cornerstone Advisors (Washington)'s Globus Medical position peaked at $84K in Q3 2018.
344 funds tracked by Wall St. Rank held Globus Medical as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.